Race in a bottle : the story of BiDil and racialized medicine in a post-genomic age /
Approved by the FDA in 2005 as the first drug with a race-specific indication on its label, BiDil was touted as a pathbreaking therapy to treat heart failure in black patients. Kahn reveals that, at the most basic level, BiDil became racial through legal maneuvering and commercial pressure as much a...
Clasificación: | Libro Electrónico |
---|---|
Autor principal: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
New York :
Columbia University Press,
2012.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Organizing race : paths toward the re-biologization of race in modern biomedical research, practice, and product development
- The birth of BiDil : how a drug becomes "ethnic"
- Statistical mischief and racial frames for drug development and marketing
- Capitalizing (on) race in drug development
- Race-ing patents/patenting race : an emerging political geography of intellectual property in biotechnology
- Not fade away : the persistence of race and the politics of the "meantime" in pharmacogenomics
- From disparity to difference : the politics of racial medicine.